AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06473402 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Knee Range of Motion
Description: Joint range of motion measurement of the participants was made with a universal goniometer. Degree was used as the measurement unit. The measurement was made in the prone position. The pivot point of the goniometer is placed on the lateral epicondyle of the femur, and the fixed arm is kept parallel to the lateral midline of the femur, while the movable arm will follow the fibula. The joint range of motion of the participants was measured before and after manual therapy. AAOS (American of Orthopedic Surgeons) was taken as the reference value.
Study NCT06473402 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Percussion Therapy
Description: A percussion massage device was used in the study. Massage application was applied to the Hamstring muscle, adhering to optimal standards. During the application, a wide round head, which is the most preferred by clinical professionals, was used and 30 Hz, which is considered as the average application speed, was used. The application was applied for a total of 6 minutes, 2 minutes for each part of the muscle. Applications have been made many times on every part of the muscle, from the starting point to the ending point.
Study NCT06473402 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual Therapy Technique
Description: Anterior and posterior innominate muscle energy techniques were performed on patients. In the anterior technique, the patient lay on their back with their leg on the diagonal shoulder. The clinician flexed the hip and knee, placed their hand on the back thigh, and instructed the patient to push, resulting in hip extension. After eight seconds, the patient inhaled and exhaled. The clinician then increased hip flexion and applied pressure against a new barrier. In the posterior technique, the patient lay on their side in the modified sims position. The clinician held the leg with their caudal hand and placed the hypothenar edge of their cranial hand on the right SIPS. The patient then pulled the leg towards themselves, applying equal counterforce for eight seconds before inhaling and exhaling. Finally, the clinician extended the leg and pushed it against a new barrier.
Study NCT05593731 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: dental implants with melatonin gel
Description: platelet rich fibrin membrane around dental implants
Study NCT05593731 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: dental implants with melatonin gel
Description: platelet rich fibrin membrane around dental implants
Study NCT05820672 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT05250778 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nudge
Description: Room intervention
Study NCT05497583 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acetone based HEMA -free universal Adhesive
Description: Teeth that meet the inclusion criteria will be selected. the operator will prepare incisal bevel. Rubber dam isolation will be used .apply etchant (phosphoric acid etching gel 37 %) only on enamel for 15 s Rinse, for 10 s Air dry to remove excess water then will apply Universal adhesive to the entire bonding surface according to manufacture instructions. Bioactive composite ( beautifill II ) will be used.
Study NCT05390450 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound-Guided Popliteal Plexus Block
Description: Patients in this group will receive Popliteal plexus block. Prior to Popliteal plexus block, the proximal end of the adductor canal will be identified. The transducer will be slid distally along the femoral artery until the artery deviated away from the sartorius muscle in the distal part of the adductor canal towards the adductor hiatus. The nerve block needle will be inserted from the anterolateral end of the transducer and advanced in-plane through the medial vastus muscle. The endpoint of injection will be inside the distal end of the adductor canal close to the adductor hiatus. The injection will be adjacent to the femoral artery, between the medial vastus muscle and the adductor magnus muscle. The Popliteal plexus block will be carried out with 10 mL of local anesthetic mixture, containing 50 mg of bupivacaine and 0.05 mg of epinephrine.
Study NCT05501808 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cerasmart
Description: the patient received a crown made of cerasmart ceramic
Study NCT05390450 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ultrasound-Guided Fascia Iliaca block
Description: Patients will be placed in a supine position, and the skin will be cleaned aseptically. The inguinal ligament from the anterior superior iliac spine to the pubic tubercle will be drawn on the skin and divided into 3 parts. The injection point was 1 cm caudally from the point where the lateral and middle part of the inguinal ligament met. The skin and deep tissues were infiltrated with 1% lidocaine. A 18G nerve block needle will be inserted into the skin perpendicularly until the first (fascia lata) and second loss of resistance (fascia iliaca) will be felt. Following aspiration to exclude intravascular injection, 40 mL of 0.25% bupivacaine (1-1.5 mg/kg), which will be prepared under aseptic conditions, and then injected. Sensorial block will be evaluated using the pinprick test 20 minutes after injection for areas of the thigh innervated by the femoral, lateral cutaneous and obturator nerves.
Study NCT06496321 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional Saphenous vein harvest
Description: The conventional one involves harvesting only the vein, without perivascular tissue or the nerve.
Study NCT06496321 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: No touch Saphenous vein harvest
Description: During the extraction of the saphenous vein using the no touch technique, it is sectioned with the perivascular adipose tissue and the saphenous nerve of the leg.
Study NCT06106321 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transalveolar crest maxillary sinus floor lift
Description: Transalveolar crest maxillary sinus floor lift + bone grafting + implant implant is used
Study NCT06106321 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: transalveolar crest parietal maxillary sinus floor secondary lift
Description: Transalveolar crest parietal maxillary sinus floor secondary lift + bone grafting + implant implantation were used body
Study NCT05501808 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: enamic
Description: the patient received a crown made of enamic ceramic
Study NCT05589038 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baby Wash/Shampoo
Description: Parent participant will bathe the baby participant with the baby wash/shampoo at least 3 times per week, but no more than once daily.
Study NCT05589038 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baby Lotion
Description: Parent participant will use the baby lotion on baby participants at least once daily.
Study NCT05497583 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Isopropanol based HEMA- free universal Adhesive
Description: Teeth that meet the inclusion criteria will be selected. the operator will prepare incisal bevel. Rubber dam isolation will be used .apply etchant (phosphoric acid etching gel 37 %) only on enamel for 15 s Rinse, for 10 s Air dry to remove excess water then will apply Universal adhesive to the entire bonding surface according to manufacture instructions. resin composite (Neo Spectra™ ST) will be used.
Study NCT05699291 — intervention group
Intervention type: OTHER
Intervention: Sentinel node detection technique
Description: Patients cared for by a surgeon for histologically proven breast cancer and for whom an indication for detection of the sentinel lymph node is posed.
Study NCT05436899 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LapSim training
Description: Complete 4 courses, each of 12 weeks, of virtual reality simulation on LapSim surgical simulator.
Study NCT05436899 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: LapSim training
Description: Complete 4 courses, each of 12 weeks, of virtual reality simulation on LapSim surgical simulator.
Study NCT05436899 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LapSim exam
Description: Completed at the beginning and at the end of each of the 4 courses the corresponding exam task.
Study NCT05436899 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: LapSim exam
Description: Completed at the beginning and at the end of each of the 4 courses the corresponding exam task.
Study NCT06039397 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Semifowler 30' Right Lateral Body Position
Description: Semifowler 30' Right Lateral Body Position Is a regulation of body position by placing the patient's body in a semi-fowler and lateral resting position of 30 degrees
Study NCT06039397 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Semifowler 30' Right Lateral Body Position
Description: Semifowler 30' Right Lateral Body Position Is a regulation of body position by placing the patient's body in a semi-fowler and lateral resting position of 30 degrees
Study NCT05857358 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: lipoaspiration
Description: Adipose tissue harvest will be conducted by a surgeon under under local and intra-veinous sedation anesthesia. Once the patient is asleep and just before the laying of the operating drapes, the skin will be thoroughly disinfected, in order to avoid bacteriological contamination. Each entry point will be disinfected with betadine before and regularly during the procedure and will receive local anesthesia.~The lipoaspiration sites will be infiltrated using a closed system, thanks to a Khoury canula. Adipose tissue will be harvested after waiting at least 5 minutes, in order to limit hematoma and excessive blood harvesting. A 3mm incision will be made then the tissue collection will be performed using a canula, manually, by gentle aspirations into a syringe then directly transferred into a connected sterile bag.~The incision will be closed with 1 stitch of 6-0 absorbable and a paraffin gauze dressing. Then, patient will be awaken and transported to the recovery room.
Study NCT05857358 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Injection of the autologous adipose-derived stromal vascular fraction (AD-SVF)
Description: Autologous uncultured (AD-SVF) will be isolated by digestion and centrifugation of adipose tissue from lipoaspiration.~Then, AD-SVF will be injected in 6 sites :~* 2 for the accessory labial glands (0.5mL in the upper lip and 0.5mL in the lower lip)~* 2 for the sublingual glands (0.5mL for each gland)~* 2 for the inner face of cheeks (0.5mL for each side)~The volume of injection will be of 3 mL containing 30 millions of AD-SVF viable nucleated cells for the total safety dose.
Study NCT06326034 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: Dapagliflozin 5 mg orally given once daily for four months.
Study NCT06444321 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: INTERCARE-HF
Description: Develpent of an individualized treatment and follow-up plan tailored to co-morbidities, risk areas, cognitive function and functional level as well as the patients' symptoms and needs.
Study NCT06444321 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: INTERCARE-HF
Description: Develpent of an individualized treatment and follow-up plan tailored to co-morbidities, risk areas, cognitive function and functional level as well as the patients' symptoms and needs.
Study NCT06571942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Beclomethasone / Formoterol / Glycopyrronyum 100/6/12.5 mcg
Description: Two inhalations twice daily form pMDI device for three months
Study NCT06409689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oliceridine fumarate low dose
Description: The first loading dose of oliceridine fumarate was 1.5 mg in all patients after operation. The PCA dose of the patients was 0.1 mg, and the locking interval was 6 min. A supplemental dose of 0.75 mg is allowed once per hour as needed after 1 h of the load dose
Study NCT06409689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oliceridine fumarate high dose
Description: The first loading dose of oliceridine fumarate was 1.5 mg in all patients after operation. The PCA dose of the patients was 0.5 mg, and the locking interval was 6 min. A supplemental dose of 0.75 mg is allowed once per hour as needed after 1 h of the load dose
Study NCT06409689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oliceridine fumarate moderate dose
Description: The first loading dose of oliceridine fumarate was 1.5 mg in all patients after operation. The PCA dose of the patients was 0.35 mg, and the locking interval was 6 min. A supplemental dose of 0.75 mg is allowed once per hour as needed after 1 h of the load dose
Study NCT06409689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: morphine
Description: The first loading dose of morphine was 4 mg in all patients after operation. The PCA dose of the patients was 1 mg, and the locking interval was 6 min. A supplemental dose of 2 mg is allowed once per hour as needed after 1 h of the load dose; The maximum cumulative daily dose is 60 mg.
Study NCT05042440 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efanesoctocog alfa
Description: Solution for injection Intravenous
Study NCT05042440 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Octocog alfa
Description: Solution for injection Intravenous
Study NCT05042440 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rurioctocog alfa pegol
Description: Solution for injection Intravenous
Study NCT06428695 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: one-hour dietary self-monitoring tool education session
Description: access the impact of a one-hour dietary self-monitoring tool education session for participants in a calorie-restricted weight management program on their knowledge of the use of the tool to help them adhere to a calorie-restricted weight management program
Study NCT06571942 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Budesonide / Formoterol / Glycopyrronyum 160/4.8/7.2 mcg
Description: Two inhalations twice daily form pMDI device for three months
Study NCT06569862 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Postoperative day 1 dressing
Description: The patient's dressing will be removed on the first day after surgery, leaving the incision exposed to air, with daily cleaning.
Study NCT06230627 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home-Based Rehabilitation rogram
Description: The intervention is distinguished from others in that it applies to patients' homes and the trial was followed up in the middle of complex conditions of the COVID-19 Pandemic. Also, the challenge was represented by the HBRP applied to patients with SCIs after 4-5 years of rehabilitation interruption.
Study NCT05321823 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iBreast device
Description: The iBreast (iBE) device is an automated, battery powered, portable device designed to be used by community health nurses as a screening and triage tool. The iBE is designed to be used by a community health worker or lay person after appropriate training. In resource-limited settings, it potentially provides an easily accessible, low-cost method to assess the breast for findings that warrant further evaluation.
Study NCT05321823 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Breast Examination
Description: The standard clinical breast examination (CBE) will be performed by the community health nurses in the selected primary health care centers where patients will present for screening or diagnostic workup in the intervention community
Study NCT05321823 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Breast ultrasound
Description: Women in the intervention community who have positive iBE and/or CBE findings will be navigated by the community health nurses to have ultrasound with or without ultrasound-guided breast biopsy if indicated by the radiologist using portable ultrasound tablets that will be brought to the intervention community.
Study NCT05321823 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Mammography
Description: Women in the intervention community who have positive iBE and/or CBE findings will be navigated by the community health nurses to have mammography done using a mobile mammography van that will be brought to the intervention community.
Study NCT05532488 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Inulin 20 mg
Description: Inulin can increase gut Bifidobacterium count. Bifidobacterium has beneficial effects on the metabolic profile and insulin resistance biomarkers.
Study NCT05532488 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05981287 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Task-oriented activities based on NDT (TOA-NDT) principle and Conventional Physical Therapy
Description: This will be a randomized clinical trial. patients are divided into two groups. one of them will undergo task-oriented activities along with conventional physical therapy treatment, while the other will undergo gross motor task training along with conventional physical therapy treatment. Purpose is to determine that which of them has greater benefit in improving balance trunk control and functional mobility in children with cerebral palsy.
Study NCT05981287 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Gross motor task training and Conventional physical therapy (CPT)
Description: This will be a randomized clinical trial. patients are divided into two groups. one of them will undergo task-oriented activities along with conventional physical therapy treatment, while the other will undergo gross motor task training along with conventional physical therapy treatment. Purpose is to determine that which of them has greater benefit in improving balance trunk control and functional mobility in children with cerebral palsy.
Study NCT04862884 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS4800 tablets
Description: 1. Drug: HRS4800 tablets Low-dose group, single oral administration~2. Drug: HRS4800 tablets Low-medium dose group, single oral administration~3. Drug: HRS4800 tablets medium -dose group, single oral administration~4. Drug: HRS4800 tablets Medium and high dose group, single oral administration~5. Drug: HRS4800 tablets High-dose group, single oral administration
Study NCT04862884 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 1. Drug: placebo Low-dose group, single oral administration~2. Drug: placebo Low-medium dose group, single oral administration~3. Drug: placebo medium -dose group, single oral administration~4. Drug: placebo Medium and high dose group, single oral administration~5. Drug: placebo High-dose group, single oral administration
Study NCT06569862 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Postoperative day 6+/-1 dressing
Description: The patient will have a daily dressing change according to the usual nursing procedures, including saline serum washing, until the sixth day (+/- 1 day) after surgery. This will be done while the patient is in hospital, or at home if discharged before the sixth day.
Study NCT05627921 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy
Description: Spastic muscles will be determined by examination. Botulinum toxin-A will be injected into the spastic muscles with Stumplex. 1 week after the injection, patients will receive 3 sessions of radial ESWT treatment, 1 session/week. rESWT application will be applied with the 'MODUS ESWT' device and a 35 mm radial soft applicator will be used. rESWT will be applied with a soft applicator. The soft applicator is designed for application to sensitive and painful areas and applications will be painless.Shock waves will be applied at 1500/beat, 8 Hz, 0.030 Mj/mm2, 2 bar per muscle.
Study NCT05627921 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botilinum Toxin injection
Description: Spastic muscles will be determined by examination. Botulinum toxin-A will be injected into the spastic muscles with Stumplex.
Study NCT06416202 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Advanced hybrid closed loop insulin pump
Description: All groups will receive comprehensive diabetes education and extensive carbohydrate counting training. Continuous glucose monitoring (CGM) will be conducted using the Guardian 4 sensor or Dexcom G6 for the intervention group depending on the type of pump used. fructosamine levels for all patients will be checked both before and after Ramadan to provide a more immediate assessment of glycemic control.
Study NCT06416202 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Open Loop Insulin Delivery system
Description: the control group will continue using their current CGM device. Data on glycemic control, hypoglycemic events, and patient satisfaction will be collected before and throughout Ramadan. Additionally, fructosamine levels for all patients will be checked both before and after Ramadan to provide a more immediate assessment of glycemic control.
Study NCT05482295 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine lot 1
Description: 3 doses of Hepatitis B vaccine lot 1
Study NCT05482295 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine lot 2
Description: 3 doses of Hepatitis B vaccine lot 2
Study NCT05482295 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine lot 3
Description: 3 doses of Hepatitis B vaccine lot 3
Study NCT05482295 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Hepatitis B vaccine (registered)
Description: 3 doses of Hepatitis B vaccine (registered)
Study NCT06248359 — intervention group
Intervention type: DRUG
Intervention: L-Arginine hydrochloride
Description: Postoperative administration of L-Arginine hydrochloride before incidence of CS-AKI